A class action suit has been proposed against Highmark Inc. arguing the company conspired with the University of Pittsburgh Medical Center to fix insurance rates. Highmark Inc. has responded by arguing the suit cannot go forward, citing a U.S. Supreme Court ruling that says damages cannot be awarded over charges involving anti-competitive behavior in rate pricing if those rate have already been approved by a regulation authority. A strategic partnership between Highmark Inc. and St. Vincent Health System had been agreed upon earlier last month in an effort for Highmark to become a stronger competitor against University of Pittsburgh Medical Center.
Featured News
Baker McKenzie Welcomes Back Former DOJ Antitrust Official
Feb 9, 2026 by
CPI
EU Flags Potential Antitrust Breach by Meta Over WhatsApp AI Restrictions
Feb 9, 2026 by
CPI
US Drops Antitrust Case Against German Fragrance Maker Symrise
Feb 9, 2026 by
CPI
Autodesk Sues Google Over Use of ‘Flow’ Trademark in AI Software Dispute
Feb 9, 2026 by
CPI
Indiana Reaches $6.25 Million Settlement in EpiPen Price-Fixing Case
Feb 9, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Hub-&-Spoke Conspiracies
Jan 26, 2026 by
CPI
A Data Analytics Company as the Hub in a Hub-and-Spoke Cartel
Jan 26, 2026 by
Joseph Harrington
Hub and Spoke Cartels
Jan 26, 2026 by
Patrick Van Cayseele
Hub-and-Spoke Collusion or Vertical Exclusion? Identifying the Rim in Hub-and-Spoke Conspiracies
Jan 26, 2026 by
Rosa Abrantes-Metz, Pedro Gonzaga, Laura Ildefonso & Albert Metz
The Algorithmic Middleman in a Hub-and-Spoke Conspiracy: Divergent Court Decisions and the Expanding Patchwork of State and Local Regulations
Jan 26, 2026 by
Bradley C. Weber